[Levofloxacin in the treatment of respiratory infections].
作者信息
Iakovlev S V, Iakovlev V P
机构信息
I. M. Sechenov Moscow Medical Academy, A. V. Vishnevsky Institute of Surgery Russian Academy of Medical Sciences, Moscow.
出版信息
Antibiot Khimioter. 2002;47(8):32-42.
PMID:12515095
Abstract
摘要
相似文献
1
[Levofloxacin in the treatment of respiratory infections].
Antibiot Khimioter. 2002;47(8):32-42.
2
The use of levofloxacin in the treatment of respiratory tract infection.
J Chemother. 2000 Oct;12 Suppl 4:27-31. doi: 10.1080/1120009x.2000.11782310.
3
4
[Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
Rev Med Liege. 2000 Nov;55(11):1015-7.
5
Clinical evaluation of levofloxacin 200 mg 3 times daily in the treatment of bacterial lower respiratory tract infections.
Drugs. 1995;49 Suppl 2:416-7. doi: 10.2165/00003495-199500492-00119.
6
Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections.
Drugs. 1995;49 Suppl 2:433-5. doi: 10.2165/00003495-199500492-00126.
7
Levofloxacin: penetration into sputum and once-daily treatment of respiratory tract infections.
Drugs. 1995;49 Suppl 2:418-9. doi: 10.2165/00003495-199500492-00120.
8
[Moxifloxacin: results of clinical use].
Antibiot Khimioter. 2002;47(10):32-6.
9
Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs).
J Chemother. 2004 Apr;16 Suppl 2:11-4. doi: 10.1080/1120009x.2004.11782367.
10
[Equally whether the child's lung or chronically inflamed bronchi. Acute bacterial infections have to be terminated fast].
MMW Fortschr Med. 2004 Mar 11;146(11):56.
Zotero 插件